Depatuxizumab MMAE

Customer Review

Based on 1 Customer Validation

Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising an anti EGFR monoclonal antibody (Depatuxizumab) (HY-P99849) and the cytotoxic agent Monomethyl auristatin E (MMAE) (HY-15162). Depatuxizumab MMAE can be used for the study of EGFR-expressing advanced solid tumors.

For research use only. We do not sell to patients.

  • Purity: 99.73%
  • Molecular Weight:148000 (average)
  • Storage:

    -80°C, protect from light

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00